Sunday, March 16, 2025 | 09:05 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

PLI scheme: Govt looks to get Rs 50,000 crore investments in pharma

The incentive will be in the range of 5-10 per cent of production value, sources said.

pharma, drugs
Premium

India imports several patented drugs, complex excipients, gene therapy products.

Sohini Das Mumbai
In what could turn out to be a major boost to local manufacturing of high-value pharmaceuticals, the Union Cabinet on Wednesday gave in-principle approval to a Rs 15,000 crore production-linked incentive (PLI) scheme for pharmaceutical products.

The government expects to attract investments worth Rs 50,000 crore from domestic and multinational drugmakers through the scheme. The incentive will be in the range of 5-10 per cent of production value, sources said.

The idea is two-pronged — to reduce imports of high-value products like patented drugs, cell-based or gene therapy products, and also boost local manufacturing to a level where India becomes a net

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in